Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19

Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19

Abstract Cancer patients are more susceptible to SARS-CoV-2 infection and generally have higher mortality rate. Anti-SARS-CoV-2 IgG is an important consideration for the patients in this COVID-19 pandemic. Recent researches suggested the rapid decay of anti-SARS-CoV-2 antibodies in the general popul...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yongsheng Huang, Jing Yu, Dan Li, Kai He, Wenyang Liu, Lin Wang, Yeshan Chen, Conghua Xie, Xiaowei Wu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/2bf4547a9fc44aaab5e7dcaaaeccfa1a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares